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Regional	  Variation	  in	  Hospitalization	  Rates:	  Causes	  and	  Implications	  
Sachin	  J.	  Shah,	  Harlan	  M.	  Krumholz.	  Section	  of	  Cardiology,	  Department	  of	  Internal	  Medicine,	  Yale	  University,	  School	  of	  
Medicine,	  New	  Haven,	  CT.	  	  
Admission	  rates	  vary	  by	  regions	  and	  states,	  but	  the	  extent	  by	  which	  variation	  in	  regional	  admission	  rates	  are	  
related	  to	  variation	  in	  the	  medical	  need	  of	  populations	  and	  the	  association	  with	  hospital	  outcomes	  is	  unknown.	  To	  
address	  these	  issues,	  we	  examine	  two	  cardiovascular	  conditions	  that	  differ	  in	  physician	  discretion	  to	  admit,	  acute	  
myocardial	  infarction	  (AMI),	  less	  discretionary,	  and	  heart	  failure	  (HF),	  more	  discretionary.	  We	  first	  determined	  
whether	  regional	  cardiovascular	  risk	  factors	  predict	  admission	  rates	  and	  then	  examined	  whether	  regional	  admission	  
rates	  were	  related	  to	  30-­‐day	  risk-­‐standardized	  mortality	  and	  readmission	  rates	  (RSMRs	  and	  RSRRs).	  	  
We	  used	  2006-­‐2008	  Medicare	  ICD-­‐9-­‐CM	  claims	  data	  and	  the	  Medicare	  Denominator	  file	  to	  determine	  AMI	  
and	  HF	  admission	  rates.	  The	  statewide	  prevalence	  of	  cardiovascular	  risk	  factors	  were	  obtained	  from	  the	  2007	  
Behavioral	  Risk	  Factor	  Surveillance	  System.	  First,	  the	  relationship	  between	  statewide	  AMI	  and	  HF	  admission	  rates	  and	  
cardiovascular	  risk	  factors	  was	  determined	  by	  a	  multivariate,	  least	  squares	  linear	  regression	  model.	  	  Second,	  
hierarchical	  logistic	  models	  were	  used	  to	  estimate	  hospital	  RSMRs	  and	  RSRRs	  and	  then	  were	  aggregated	  to	  the	  level	  
of	  hospital	  referral	  regions	  (HRRs).	  The	  correlation	  (R2)	  was	  obtained	  by	  linear	  regression	  to	  characterize	  the	  
relationship	  between	  both	  AMI	  and	  HF	  admission	  rates	  and	  regional	  RSMRs	  and	  RSRRs.	  Where	  significant	  
relationships	  were	  observed,	  “cross	  condition”	  analyses	  were	  performed	  comparing	  admission	  rates	  of	  one	  condition	  
against	  the	  RSMR	  or	  RSRR	  of	  the	  other	  in	  an	  effort	  identify	  potentially	  confounded	  relationships.	  	  
In	  the	  first	  analysis,	  cardiovascular	  risk	  factors	  explained	  49%	  of	  the	  variation	  observed	  in	  statewide	  AMI	  
admission	  rates	  and	  50%	  of	  the	  variation	  in	  HF	  admission	  rates.	  In	  the	  second	  analysis,	  regional	  AMI	  admission	  rate	  
was	  not	  correlated	  with	  AMI	  RSMR	  (R2	  0.01,	  95%	  CI	  0.00-­‐0.04).	  Regional	  HF	  admission	  rate	  was	  inversely	  correlated	  
with	  HR	  RSMR	  (R2	  0.13,	  95%	  CI	  0.07-­‐0.21).	  Regional	  AMI	  hospitalization	  rate	  was	  weakly	  correlated	  with	  AMI	  RSRR	  (R2	  
0.05,	  95%	  CI	  0.02-­‐0.11).	  Regional	  HF	  admission	  rate	  was	  modestly	  correlated	  with	  HF	  RSRR	  (R2	  0.25,	  95%	  CI	  0.17-­‐
0.34).	  In	  the	  cross	  condition	  analyses,	  regional	  HF	  admission	  rate	  was	  not	  associated	  with	  AMI	  RSMR	  (R2	  0.00,	  95%	  CI	  
0.00-­‐0.02)	  but	  was	  associated	  with	  AMI	  RSRR	  (R2	  0.25,	  95%	  CI	  0.17-­‐0.34).	  	  
Cardiovascular	  risk	  factors	  explain	  part,	  but	  not	  all,	  of	  the	  variation	  in	  AMI	  and	  HF	  admission	  rates.	  The	  
modest	  association	  between	  regional	  HF	  admission	  rate,	  a	  more	  discretionary	  admission	  condition,	  and	  both	  AMI	  and	  
HF	  RSRRs	  suggests	  a	  system	  propensity	  to	  patients.	  The	  same	  was	  not	  seen	  true	  of	  AMI	  a	  less	  discretionary	  admission	  
condition.	  The	  modest	  inverse	  relationship	  between	  regional	  HF	  admission	  rate	  and	  HF	  RSMR,	  which	  was	  not	  
observed	  with	  AMI	  RSMR,	  suggests	  an	  unmeasured	  confounder	  affecting	  the	  HF	  RSMR	  model.	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Introduction	  
Beginnings	  of	  Small	  Area	  Variation	  Research	  
Nearly	  40	  years	  ago,	  Dr.	  John	  Wennberg	  published	  a	  landmark	  paper	  in	  Science	  
entitled	  “Small	  Area	  Variations	  in	  Health	  Care	  Delivery.”	  Based	  on	  observations	  from	  
Vermont’s	  health	  care	  delivery	  monitoring	  system,	  he	  demonstrated	  that	  the	  utilization	  
of	  inpatient	  hospitalization	  and	  surgical	  procedures	  varied	  dramatically	  between	  
neighboring	  hospitals.1	  	  
Wennberg	  and	  others	  went	  on	  to	  show	  that	  admission	  rates	  for	  discretionary	  
medical	  conditions	  such	  as	  heart	  failure,	  and	  surgical	  procedures	  such	  as	  hysterectomy,	  
varied	  as	  much	  as	  400%.2-­‐4	  Furthermore,	  admission	  rates	  for	  discretionary	  conditions	  
were	  observed	  to	  be	  highly	  correlated	  with	  supply	  characteristics,	  such	  as	  hospital	  bed	  
per	  capita	  and	  number	  of	  health	  care	  employees	  per	  capita.5	  In	  contrast,	  non-­‐
discretionary	  admission	  such	  as	  hip	  fracture	  and	  acute	  myocardial	  infarction	  showed	  
relatively	  little	  variation	  in	  regional	  rates	  and	  were	  not	  associated	  with	  supply	  
characteristics.4	  These	  conditions	  were	  identified	  as	  non-­‐discretionary	  based	  on	  two	  key	  
features.	  First,	  nearly	  all	  patients	  who	  experienced	  these	  conditions	  presented	  to	  
hospitals.	  Second,	  and	  more	  importantly,	  when	  patients	  with	  these	  conditions	  
presented	  to	  hospital	  emergency	  departments,	  they	  were	  all	  admitted	  for	  inpatient	  
care.	  	  
This	  phenomenon	  was	  not	  limited	  to	  Vermont.	  Similar	  observations	  of	  marked	  
variation	  in	  utilization	  of	  discretionary	  surgical	  procedures	  were	  made	  across	  the	  United	  
	  	   5	  
States	  and	  internationally	  in	  countries	  such	  as	  Norway,	  the	  United	  Kingdom	  and	  
Canada.3	  This	  observation	  -­‐-­‐	  that	  marked	  variation	  occurs	  within	  nations	  with	  vastly	  
different	  health	  care	  systems	  -­‐-­‐	  led	  Wennberg	  to	  propose	  a	  theory	  called	  “practice	  style	  
factor.”4	  Variation	  in	  inpatient	  utilization,	  he	  proposed,	  was	  highest	  for	  conditions	  in	  
which	  there	  was	  little	  consensus	  in	  the	  benefit	  of	  hospitalization	  or	  surgical	  
intervention.	  Where	  there	  was	  a	  clear	  understanding	  of	  the	  need	  to	  hospitalize	  patients	  
as	  in	  the	  event	  of	  AMI	  or	  a	  hip	  fracture,	  he	  noted	  there	  was	  minimal	  regional	  variation	  in	  
hospitalization	  rates.	  4,	  6	  In	  a	  commentary	  in	  Health	  Affairs	  in	  1984	  Wennberg	  notes	  that	  
this	  variation	  exists	  not	  only	  to	  the	  potential	  detriment	  of	  patients	  who	  may	  be	  
hospitalized	  for	  unnecessarily,	  but	  also	  to	  the	  potential	  detriment	  of	  society	  who	  bears	  
the	  cost	  of	  hospitalizations.6	  	  
Today	  in	  2011,	  the	  causes	  and	  consequences	  of	  regional	  variation	  in	  
hospitalization	  rates	  have	  taken	  on	  renewed	  and	  substantive	  importance	  through	  the	  
passage	  of	  the	  Patient	  Protection	  and	  Affordable	  Care	  Act	  of	  2010.	  The	  law	  allows	  for	  
accountable	  care	  organizations	  (ACOs)	  -­‐-­‐	  a	  regional	  network	  of	  health	  care	  providers	  -­‐-­‐	  
to	  negotiate	  contracts	  with	  Medicare	  on	  the	  basis	  of	  quality	  and	  efficient	  delivery	  of	  
services.	  However,	  when	  it	  comes	  to	  inpatient	  care,	  there	  exists	  a	  rudimentary	  
understanding	  of	  the	  causes	  and	  consequences	  associated	  with	  variation	  in	  regional	  
admission	  rates.	  This	  limited	  understanding	  is	  exemplified	  by	  the	  broad	  options	  
previously	  considered	  by	  the	  Centers	  for	  Medicare	  and	  Medicaid	  Services	  to	  reduce	  
spending	  such	  as	  reducing	  reimbursements	  to	  hospitals	  in	  areas	  where	  the	  elective	  
admission	  rate	  exceeds	  120%	  of	  the	  national	  average.7	  In	  this	  setting,	  where	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reimbursement	  may	  be	  tied	  to	  efficiency	  of	  care	  delivered,	  there	  is	  little	  consensus	  as	  to	  
what	  constitutes	  appropriate	  population	  level	  admission	  rates.	  	  In	  this	  two-­‐part	  study,	  
we	  examine	  two	  distinct	  facets	  of	  regional	  variation	  in	  admission	  rates:	  (1)	  do	  regional	  
risk	  profiles	  explain	  variation	  in	  regional	  hospitalization	  rates	  for	  specific	  medical	  
conditions?	  and	  (2)	  among	  the	  patients	  hospitalized,	  do	  regional	  hospitalization	  rates	  
explain	  regional	  differences	  in	  patient	  mortality	  and	  readmission?	  
We	  provide	  additional	  background	  for	  each	  question	  and	  go	  on	  to	  describe	  how	  
we	  seek	  to	  contribute	  to	  the	  understanding	  of	  what	  constitutes	  appropriate	  use	  of	  
inpatient	  care.	  
Part	  I:	  Medical	  Need	  and	  Inpatient	  Utilization	  
	   The	  first	  step	  to	  better	  understand	  regional	  variation	  in	  hospitalization	  rates	  is	  to	  
ascertain	  whether	  this	  variation	  is	  reflective	  of	  the	  underlying	  medical	  need	  of	  the	  
population.	  Quantifying	  medical	  need,	  however,	  can	  be	  difficult.	  While	  studies	  that	  have	  
examined	  this	  issue	  disagree	  about	  the	  exact	  contribution	  of	  population	  health	  towards	  
hospitalization	  rates,	  in	  collective,	  they	  made	  clear	  that	  it	  is	  implausible	  that	  differences	  
in	  patient	  characteristics	  account	  for	  the	  variation	  in	  hospitalization	  rates.2,	  3,	  6,	  8,	  9	  
Nevertheless,	  the	  broad	  applicability	  of	  these	  findings	  has	  been	  hampered	  by	  one	  or	  
more	  of	  the	  following	  study	  characteristics:	  
(1) Examination	  of	  general	  health	  and	  total	  hospitalization	  rates	  but	  lacking	  
specificity	  to	  a	  particular	  disease	  process;2,	  5,	  8-­‐14	  
(2) Examination	  hospitalization	  rates	  using	  patient	  level	  predictors	  from	  a	  nationally	  
representative	  sample,	  which	  by	  its	  very	  design,	  could	  not	  by	  measure	  the	  effect	  
	  	   7	  
of	  regional	  differences	  in	  practices	  regarding	  inpatient	  use,	  also	  known	  as	  
individual	  fallacy;11	  and/or	  
(3) Examination	  of	  hospitalization	  rates	  of	  a	  few	  select	  regions	  that	  could	  not	  be	  
reasonably	  extrapolated	  to	  the	  entire	  nation.12,	  15,	  16	  	  
Studies	  have	  yet	  to	  make	  use	  of	  high	  quality,	  multifaceted	  regional	  health	  risk	  
factor	  data	  to	  examine	  the	  association	  between	  regional	  health	  risk	  profile	  and	  
hospitalization	  rates	  across	  the	  entire	  nation.	  Furthermore,	  the	  relationship	  between	  
condition-­‐specific	  risk	  profile	  and	  hospitalization	  rates	  remains	  unexamined.	  	  
Prior	  work	  has	  demonstrated	  that	  general	  hospitalization	  rates	  are	  largely	  
independent	  of	  population	  risk	  profile.	  In	  Part	  I	  of	  this	  study,	  we	  propose	  a	  focused	  
examination	  of	  the	  degree	  to	  which	  variation	  in	  regional	  cardiovascular	  hospitalization	  
rates	  are	  unexplained	  by	  differences	  in	  regional	  cardiovascular	  risk	  profiles.	  More	  
specifically,	  we	  propose	  an	  examination	  of	  hospitalization	  rates	  for	  acute	  myocardial	  
infarction	  (AMI),	  a	  less	  discretionary	  condition	  and	  heart	  failure	  (HF),	  a	  more	  
discretionary	  condition.	  We	  specify	  cardiovascular	  disease	  because	  of	  the	  extensive	  
body	  of	  research	  identifying	  risk	  factors	  and	  the	  ongoing	  collection	  of	  cardiovascular	  risk	  
factor	  data	  through	  the	  Centers	  for	  Disease	  Control	  programs	  such	  as	  the	  Behavioral	  
Risk	  Factor	  Surveillance	  System	  (BRFSS)	  -­‐-­‐	  a	  high	  quality	  and	  validated	  regional	  health	  
surveillance	  database	  with	  detailed	  data	  of	  the	  prevalence	  of	  cardiovascular	  risk	  
factors.17	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   To	  reiterate,	  our	  goal	  is	  to	  identify	  how	  much	  of	  the	  regional	  variation	  in	  AMI	  
and	  HF	  hospitalization	  rates	  is	  explained	  by	  regional	  variation	  in	  cardiovascular	  risk	  
profile.	  	  
Part	  II:	  Inpatient	  Utilization	  and	  Patient	  Outcomes	  
Beyond	  the	  need	  to	  examine	  the	  relationship	  between	  regional	  hospitalization	  
rates	  and	  risk	  profiles,	  there	  has	  been	  a	  long	  articulated	  need	  to	  examine	  the	  extent	  to	  
which	  difference	  in	  regional	  health	  outcomes	  are	  explained	  by	  regional	  differences	  in	  
hospitalization	  rates.16,	  18,	  19	  Prior	  studies	  have	  worked	  to	  answer	  this	  question	  adding	  
key	  insights	  into	  the	  nature	  of	  this	  relationship.12,	  15,	  16	  	  
The	  most	  famous	  of	  these	  studies	  compared	  hospitalization	  rates	  and	  patient	  
outcomes	  in	  New	  Haven	  and	  Boston.12,	  15,	  16	  Using	  a	  retrospective	  design	  examining	  
select	  regions	  Wennberg	  demonstrated	  that	  Boston	  had	  higher	  hospitalization	  rates	  for	  
discretionary	  conditions,	  a	  longer	  length	  of	  stay,	  and	  greater	  per	  patient	  
reimbursements	  from	  Medicare.15,	  16	  Despite	  this	  disparity	  in	  hospitalization	  rates,	  New	  
Haven	  and	  Boston	  had	  the	  same	  age-­‐,	  sex-­‐	  and	  race-­‐adjusted	  mortality	  rate.	  	  Fisher	  
followed	  up	  using	  the	  same	  construct	  to	  determine	  if	  readmission	  rates	  varied	  between	  
Boston	  and	  New	  Haven.12	  Among	  patients	  hospitalized	  for	  non-­‐discretionary	  conditions,	  
Fisher	  found	  that	  risk-­‐standardized	  readmission	  rates	  were	  higher	  in	  Boston	  relative	  to	  
New	  Haven.	  These	  studies	  provided	  a	  detailed	  portrait	  of	  two	  cities	  with	  similar	  patient	  
populations	  and	  significantly	  different	  hospitalization	  rates	  with	  no	  discernable	  
difference	  in	  patient	  outcomes.	  While	  this	  question	  was	  first	  explored	  by	  Wennberg	  and	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Fisher	  the	  limitation	  of	  these	  analyses	  lies	  in	  the	  inability	  to	  extrapolate	  these	  findings	  
beyond	  New	  Haven	  and	  Boston.	  	  	  	  
Since	  their	  publication	  17	  years	  ago,	  there	  have	  been	  two	  major	  advances	  that	  
allow	  for	  a	  nationwide	  analysis.	  First,	  data	  on	  condition	  specific	  hospitalization	  rates	  are	  
readily	  available	  for	  every	  region	  in	  the	  nation.	  	  Second,	  there	  have	  been	  key	  advances	  
in	  the	  field	  of	  measurement	  science.	  	  The	  use	  of	  hierarchical	  generalized	  linear	  models	  
has	  allowed	  for	  more	  accurate	  estimation	  of	  risk-­‐standardized	  readmission	  and	  
mortality	  rates.	  Specifically,	  risk-­‐standardized	  readmission	  and	  mortality	  rates	  
developed	  by	  Krumholz	  et	  al.	  use	  hierarchical	  models	  that	  draw	  upon	  demographics	  and	  
longitudinal	  patient-­‐level	  clinical	  data	  to	  appropriately	  risk	  adjust.20-­‐22	  These	  measures	  
are	  endorsed	  the	  National	  Quality	  Forum	  and	  are	  produced	  for	  the	  Centers	  of	  Medicare	  
and	  Medicaid	  Services	  (CMS).	  	  Furthermore,	  risk-­‐standardized	  readmission	  and	  mortality	  
rates	  for	  heart	  failure,	  acute	  myocardial	  infarction	  and	  pneumonia	  are	  calculated	  for	  
every	  hospital	  and	  are	  publicly	  reported	  CMS.	  In	  essence,	  these	  risk-­‐standardized	  
outcomes	  measures	  provide	  a	  widely	  accepted	  indication	  of	  quality	  –	  patient	  
readmission	  and	  mortality	  –	  independent	  of	  patient	  characteristics.	  
In	  Part	  II	  of	  this	  study,	  we	  examine	  whether	  variation	  in	  risk-­‐standardized	  
readmission	  and	  mortality	  rates	  is	  explained	  by	  variation	  in	  hospitalization	  rates.	  	  
Specifically	  we	  examine	  this	  relationship	  for	  two	  cardiovascular	  conditions,	  AMI	  and	  HF.	  
Hospitalization	  Rates	  and	  Risk-­‐Standardized	  AMI	  and	  HF	  Outcomes	  
	  	  AMI	  hospitalization	  rates	  have	  previously	  been	  shown	  to	  vary	  moderately	  from	  
region	  to	  region.	  In	  addition,	  hospitalization	  for	  AMI	  is	  considered	  to	  be	  largely	  non-­‐
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discretionary,	  meaning	  community	  incidence	  is	  thought	  to	  approximate	  hospitalization	  
rates.	  	  	  
Given	  the	  nature	  of	  AMI	  hospitalizations,	  we	  expect	  regional	  AMI	  risk-­‐
standardized	  readmission	  rates	  to	  vary	  independently	  of	  AMI	  hospitalization	  rates.	  	  	  
	  
Stated	  differently,	  we	  expect	  there	  to	  be	  no	  association	  between	  regional	  AMI	  
risk-­‐standardized	  readmission	  rates	  and	  AMI	  hospitalization	  rates	  (Box	  1).	  For	  similar	  
reasons,	  we	  hypothesize	  no	  association	  regional	  AMI	  risk-­‐standardized	  mortality	  rates	  
and	  AMI	  hospitalization	  rates	  (Box	  2).	  	  
On	  the	  other	  hand,	  HF	  hospitalization	  rates	  have	  previously	  been	  shown	  to	  vary	  
highly	  from	  region	  to	  region.	  In	  addition,	  hospitalization	  for	  HF	  is	  considered	  to	  be	  more	  	  
	  
discretionary	  and	  dependent	  on	  hospital	  and	  regional	  practices.	  For	  instance,	  given	  the	  
same	  circumstances,	  a	  hypothetical	  patient	  hospitalized	  in	  one	  region	  may	  be	  treated	  as	  
an	  outpatient	  and	  not	  hospitalized	  in	  another	  region.	  Given	  the	  discretionary	  nature	  of	  
HF	  hospitalizations,	  we	  expect	  that	  regional	  HF	  risk-­‐standardized	  readmission	  rates	  are	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explained	  in	  part	  by	  regional	  HF	  hospitalization	  rates.	  	  Stated	  differently,	  we	  expect	  an	  
association	  between	  regional	  HF	  risk-­‐standardized	  readmission	  rates	  and	  HF	  
hospitalization	  rates	  (Box	  1).	  While	  we	  hypothesize	  that	  regional	  HF	  risk-­‐standardized	  
readmission	  rates	  are	  explained	  in	  part	  by	  hospitalization	  rates,	  we	  expect	  no	  
relationship	  between	  regional	  HF	  risk-­‐standardized	  mortality	  rates	  and	  HF	  
hospitalization	  rates	  (Box	  2).	  	  That	  is,	  while	  healthier	  patients	  may	  be	  admitted	  in	  
regions	  with	  high	  HF	  hospitalization	  rates,	  our	  expectation	  is	  that	  the	  risk	  adjustment	  in	  
the	  mortality	  model	  will	  appropriately	  reflect	  the	  decreased	  risk	  of	  mortality	  among	  
these	  healthier	  patients.	  	  
Exploring	  Unmeasured	  Confounders	  as	  Alternative	  Explanations	  
When	  examining	  the	  relationship	  between	  hospitalization	  rates	  and	  risk-­‐
standardized	  readmission	  rates,	  if	  all	  assumptions	  are	  accepted,	  then	  a	  correlation,	  
positive	  or	  inverse,	  would	  indicated	  that	  regional	  variation	  in	  outcomes	  is	  explained	  in	  
part	  by	  variation	  in	  hospitalization	  rates.	  However,	  in	  examining	  all	  possible	  
explanations,	  assumptions	  must	  be	  questioned	  and	  further	  investigated.	  One	  particular	  
assumption	  is	  that	  the	  risk-­‐standardized	  readmission	  model	  is	  unbiased	  and	  an	  observed	  
relationship	  is	  not	  confounded.	  For	  example,	  earlier	  we	  hypothesized	  a	  positive	  
association	  between	  regional	  HF	  hospitalization	  rates	  and	  HF	  risk-­‐standardized	  
readmission	  rates.	  This	  may	  indicate	  lower	  quality	  in	  higher	  HF	  hospitalization	  regions	  or	  
it	  may	  be	  the	  product	  of	  a	  systematic	  bias	  in	  the	  risk-­‐standardized	  readmission	  model	  
giving	  the	  appearance	  of	  poor	  quality	  in	  regions	  with	  higher	  HF	  hospitalization	  rates.	  In	  
particular,	  in	  this	  example,	  an	  alternative	  explanation	  is	  that	  regions	  with	  high	  HF	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hospitalization	  rates	  treat	  a	  sicker	  patient	  population	  (hence	  the	  high	  hospitalization	  
rate)	  who	  are	  also	  sicker	  in	  ways	  not	  captured	  by	  the	  HF	  risk-­‐standardized	  readmission	  
model.	  This,	  in	  effect,	  would	  give	  the	  appearance	  of	  poor	  quality	  by	  way	  of	  higher	  
readmission	  rates	  in	  regions	  with	  high	  HF	  hospitalization	  rates	  when	  in	  reality	  the	  
observed	  relationship	  is	  confounded.	  	  To	  address	  this	  issue,	  we	  plan	  to	  perform	  “cross	  
condition	  analyses.”	  Continuing	  with	  the	  current	  example,	  to	  further	  analyze	  the	  
relationship	  between	  regional	  HF	  hospitalization	  rates	  and	  HF	  risk-­‐standardized	  
readmission	  rates,	  we	  would	  examine	  the	  relationship	  between	  regional	  HF	  
hospitalization	  rate	  and	  regional	  AMI	  risk-­‐standardized	  readmission	  rate.	  This	  analysis	  
allows	  us	  to	  provide	  additional	  evidence	  to	  discern	  whether	  an	  observed	  relationship	  is	  
causal	  or	  confounded.	  In	  theory,	  the	  two	  are	  unrelated	  and	  should	  produce	  no	  
correlation.	  	  However,	  if	  a	  similar	  positive	  association	  is	  observed	  between	  regional	  HF	  
hospitalization	  rates	  and	  both	  HF	  and	  AMI	  risk-­‐standardized	  readmission	  rates,	  then	  it	  
may	  be	  taken	  as	  evidence	  of	  a	  causal	  relationship;	  specifically,	  that	  the	  observed	  
positive	  relationship	  between	  HF	  hospitalization	  rates	  and	  HF	  risk-­‐standardized	  
readmission	  rates	  indicates	  lower	  quality	  in	  high	  admitting	  regions.	  	  On	  the	  other	  hand,	  
if	  the	  relationship	  observed	  between	  regional	  HF	  hospitalization	  rate	  and	  HF	  risk-­‐
standardized	  readmission	  rates	  was	  not	  observed	  between	  regional	  HF	  hospitalization	  
rate	  and	  AMI	  risk-­‐standardized	  readmission	  rates,	  then	  it	  may	  be	  taken	  as	  evidence	  of	  a	  
confounded	  relationship;	  specifically,	  that	  observed	  positive	  relationship	  between	  HF	  
hospitalization	  rates	  and	  HF	  risk-­‐standardized	  readmission	  rate	  is	  confounded	  by	  an	  
unmeasured	  variable	  such	  as	  sickness	  of	  the	  patient	  population	  (Box	  3).	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As	  outlined	  above,	  given	  the	  discretionary	  nature	  of	  HF	  admissions,	  we	  
hypothesize	  a	  positive	  correlation	  between	  regional	  HF	  hospitalization	  rate	  and	  HF	  risk-­‐
standardized	  readmission	  rate.	  Further,	  we	  believe	  this	  is	  a	  causal	  relationship	  and	  not	  
due	  to	  an	  unmeasured	  confounder.	  Therefore,	  we	  also	  hypothesize	  a	  positive	  
correlation	  between	  regional	  HF	  hospitalization	  rate	  and	  AMI	  risk-­‐standardized	  
readmission	  rate.	  As	  previously	  stated,	  hospitalization	  for	  AMI	  is	  believed	  to	  be	  a	  non-­‐
discretionary	  and	  as	  such	  we	  expect	  neither	  a	  relationship	  between	  regional	  AMI	  
hospitalization	  rate	  and	  AMI	  risk-­‐standardized	  readmission	  rate	  nor	  a	  relationship	  with	  
HF	  risk-­‐standardized	  readmission	  rate.
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Hypothesis	  and	  Specific	  Aims	  
Central	  Hypotheses:	  	  
Hypothesis	  1	   There	  is	  significant	  regional	  variation	  in	  the	  hospitalization	  rates	  for	  
cardiovascular	  diseases	  such	  HF	  and	  AMI	  	  
Hypothesis	  2	   Cardiovascular	  need,	  as	  defined	  by	  the	  risk	  profile,	  explains	  only	  part	  of	  the	  
variation	  observed	  in	  HF	  and	  AMI	  hospitalization	  rates	  	  
Hypothesis	  3	   Variation	  in	  regional	  risk-­‐standardized	  readmission	  rates	  is	  explained	  in	  part	  by	  
variation	  in	  regional	  hospitalization	  rates	  for	  HF,	  a	  more	  discretionary	  condition,	  
but	  not	  regional	  hospitalization	  rates	  for	  AMI,	  a	  less	  discretionary	  condition.	  	  
Hypothesis	  1:	  Specific	  Aim	  
Variation	  in	  admission	  rates	  is	  highest	  for	  discretionary	  conditions	  such	  as	  HF	  and	  variation	  in	  
admission	  rates	  is	  lowest	  for	  conditions	  that	  have	  been	  less	  discretionary	  such	  as	  AMI	  
Hypothesis	  2:	  Specific	  Aims	  	  
Aim	  2.1 Individual	  cardiovascular	  risk	  factors	  are	  associated	  with	  regional	  variation	  in	  HF	  and	  
AMI	  admission	  rates	  
Aim	  2.2 Regional	  variation	  in	  HF	  and	  AMI	  hospitalization	  rates	  are	  incompletely	  explained	  by	  
regional	  variation	  in	  cardiovascular	  risk	  profile	  	  
Hypothesis	  3:	  Specific	  Aims	  
Aim	  3.1 There	  is	  no	  association	  between	  regional	  AMI	  hospitalization	  rate	  and	  AMI	  risk-­‐
standardized	  readmission	  rates	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Aim	  3.2 There	  is	  a	  positive	  association	  between	  regional	  HF	  admission	  rate	  and	  HF	  risk-­‐
standardized	  readmission	  rates	  
Aim	  3.3 There	  is	  no	  association	  between	  regional	  AMI	  hospitalization	  rate	  and	  HF	  risk-­‐
standardized	  readmission	  rates	  reinforcing	  the	  hypothesis	  that	  variation	  in	  risk-­‐
standardized	  readmission	  rates	  is	  unexplained	  by	  variation	  in	  AMI	  hospitalization	  
rates	  
Aim	  3.4 There	  is	  a	  positive	  association	  between	  regional	  HF	  admission	  rate	  and	  AMI	  risk-­‐
standardized	  readmission	  rate	  reinforcing	  the	  hypothesis	  that	  variation	  in	  risk-­‐
standardized	  readmission	  rate	  is	  explained,	  in	  part,	  by	  variation	  in	  HF	  hospitalization	  
rates	  (i.e.	  evidence	  for	  a	  causal	  relationship)	  
Aim	  3.5 There	  is	  a	  no	  association	  between	  regional	  AMI	  admission	  rate	  and	  AMI	  risk-­‐
standardized	  mortality	  rate	  
Aim	  3.6 There	  is	  a	  no	  association	  between	  regional	  HF	  admission	  rate	  and	  HF	  risk-­‐
standardized	  mortality	  rate	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Methods	  
State	  and	  Regional	  Admission	  Rates	  and	  Variation	  
The	  study	  population	  included	  Medicare	  fee-­‐for-­‐services	  patients,	  age	  65	  and	  
older	  that	  were	  hospitalized	  between	  January	  1,	  2006	  and	  December	  31,	  2008.	  Patients	  
with	  principal	  discharge	  diagnosis	  of	  AMI	  and	  HF,	  as	  determined	  by	  International	  
Classification	  of	  Diseases,	  9th	  Revision,	  Clinical	  Modification,	  were	  included	  (please	  see	  
supplemental	  table	  A	  and	  B	  for	  details).	  Data	  were	  obtained	  from	  the	  MedPAR	  dataset,	  
a	  subset	  of	  the	  standard	  analytic	  files	  and	  enrollment	  databases	  of	  the	  Center	  for	  
Medicare	  and	  Medicaid	  Services.	  
For	  this	  analysis,	  all	  admissions	  meeting	  the	  abovementioned	  criteria	  were	  
included.	  Admission	  data	  was	  linked	  to	  the	  2006	  American	  Hospital	  Association	  (AHA)	  
Annual	  Survey	  of	  Hospitals	  using	  Medicare	  Provider	  ID	  by	  Medicare	  Provider	  ID	  (variable	  
“HCFAID”).23	  Using	  geographic	  information	  in	  the	  2006	  AHA	  Annual	  Survey	  of	  Hospitals,	  
admissions	  were	  aggregated	  to	  the	  hospital	  referral	  region	  (HRR)	  and	  state	  level.	  HRR	  
are	  306	  functional	  geographic	  regions	  created	  based	  on	  patterns	  of	  referral	  for	  complex	  
cardiac	  surgeries	  and	  neurosurgical	  procedures.24	  They	  are	  used	  as	  a	  proxy	  hospital	  and	  
regional	  catchment	  areas	  in	  order	  to	  study	  regional	  variation.9,	  26-­‐29	  Medicare	  enrollment	  
for	  each	  HRR	  and	  state	  was	  obtained	  from	  the	  Dartmouth	  Atlas	  Project.25	  	  
Admission	  rates	  for	  AMI	  and	  HF	  were	  obtained	  by	  dividing	  the	  annual	  regional	  
admissions	  by	  regional	  enrollment.	  Variation	  in	  the	  admission	  rates	  among	  the	  306	  
HRRs	  was	  calculated	  using	  a	  volume-­‐weighted	  coefficient	  of	  variation	  (CV).	  Using	  the	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coefficient	  of	  variation	  was	  more	  advantageous	  than	  using	  standard	  deviation	  (σ)	  
because	  as	  a	  dimensionless,	  scale	  invariant	  metric,	  it	  allows	  for	  the	  comparison	  of	  




However,	  if	  there	  are	  n	  regions	  and	  if	  wi	  is	  the	  population	  of	  the	  ith	  region,	  then	  the	  






Part	  I:	  Defining	  and	  Assessing	  Cardiovascular	  Risk	  Profile	  
	   We	  defined	  cardiovascular	  risk	  profile	  as	  the	  prevalence	  of	  cardiovascular	  risk	  
factors	  in	  a	  given	  region.	  	  We	  used	  data	  from	  the	  2007	  Behavioral	  Risk	  Factor	  
Surveillance	  System	  (BRFSS)	  to	  assess	  the	  burden	  of	  cardiovascular	  risk	  factor	  in	  each	  
state.	  	  The	  BRFSS	  is	  a	  high	  quality	  and	  validated	  on-­‐going	  telephone	  survey	  system,	  
tracking	  self-­‐reported	  health	  conditions	  and	  risk	  behaviors	  across	  the	  United	  States.17,	  27	  
Cardiovascular	  risk	  factors	  were	  chosen	  based	  on	  the	  existing	  literature	  and	  included	  the	  
community	  prevalence	  of	  diabetes,	  hyperlipidemia,	  obesity,	  hypertension,	  
angina/coronary	  artery	  disease,	  tobacco	  use,	  inactivity,	  and	  history	  of	  prior	  myocardial	  
infarction	  (please	  see	  supplemental	  table	  C	  for	  detailed	  description	  of	  the	  variables	  
used).28-­‐33	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Part	  I:	  Statewide	  Admission	  Rates	  
Cardiovascular	  surveillance	  data	  in	  its	  most	  detailed	  form,	  from	  BRFSS	  or	  any	  
other	  source	  is	  only	  available	  at	  the	  state	  level.	  	  Therefore,	  for	  the	  analyses	  in	  Part	  I,	  
admission	  counts	  were	  aggregated	  to	  the	  state	  level	  and	  statewide	  enrollment	  data	  was	  
used	  to	  calculate	  statewide	  hospitalization	  rates	  for	  AMI	  and	  HF.	  	  
Part	  I:	  Statistical	  Analysis	  
	   First,	  we	  conducted	  bivariate	  analyses	  to	  compare	  the	  statewide	  prevalence	  of	  
individual	  cardiovascular	  risk	  factors	  and	  statewide	  admission	  rates	  for	  AMI	  and	  HF.	  	  
	   Then,	  we	  used	  a	  population-­‐weighted	  standard	  least	  squares	  regression	  model	  
to	  estimate	  the	  relationship	  between	  the	  prevalence	  of	  all	  cardiovascular	  risk	  factors	  
and	  statewide	  hospitalization	  rates	  for	  AMI	  and	  HF.	  Because	  our	  objective	  in	  this	  
analysis	  was	  to	  determine	  the	  predictive	  power	  of	  cardiovascular	  risk	  profile	  as	  defined	  
by	  the	  aggregate	  of	  cardiovascular	  risk	  factors,	  colinearity	  of	  individual	  parameters	  in	  
the	  model	  was	  not	  considered.	  Had	  our	  objective	  been	  to	  determine	  the	  individual	  
drivers	  of	  the	  relationship	  between	  cardiovascular	  risk	  factors	  and	  hospitalization	  rates,	  
a	  model	  with	  minimal	  colinearity	  would	  have	  been	  developed.	  	  	  
Part	  II:	  Study	  Population	  for	  Risk	  Standardized	  Readmission	  and	  Mortality	  Rates	  
Risk-­‐standardized	  readmission	  rates	  and	  risk-­‐standardized	  mortality	  rates	  were	  
calculated	  based	  on	  the	  population	  of	  Medicare	  fee-­‐for-­‐service	  patients,	  65	  years	  of	  age	  
and	  older	  who	  were	  hospitalized	  between	  January	  1,	  2006	  and	  December	  31,	  2008.	  	  
Patients	  who	  had	  a	  principle	  discharge	  diagnosis	  of	  AMI	  and	  HF,	  as	  determined	  by	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International	  Classification	  of	  Diseases,	  9th	  Revision,	  Clinical	  Modification	  were	  included	  
(please	  see	  supplemental	  table	  A	  and	  B	  for	  details).	  Data	  were	  obtained	  from	  the	  
MedPAR	  dataset,	  a	  subset	  of	  the	  standard	  analytic	  files	  and	  enrollment	  databases	  of	  the	  
Center	  for	  Medicare	  and	  Medicaid	  Services.	  This	  data	  from	  2006	  to	  2008	  included	  
demographic	  information,	  principal	  and	  secondary	  discharge	  diagnoses	  codes,	  
procedure	  codes	  and	  discharge	  disposition.	  	  We	  included	  patients	  with	  12	  months	  of	  
continuous	  enrollment	  in	  Medicare	  fee-­‐for-­‐service	  prior	  to	  hospitalization	  to	  obtain	  
existing	  comorbid	  conditions	  for	  the	  purpose	  of	  risk	  adjustment.	  Medicare	  Part	  A	  and	  B	  
data	  were	  used	  to	  determine	  patients’	  existing	  comorbidities,	  medical	  history	  and	  use	  of	  
procedures	  in	  the	  12	  months	  prior	  to	  the	  indexed	  admission.	  Patients	  who	  were	  
transferred	  during	  a	  hospitalization	  were	  linked	  into	  a	  single	  episode	  of	  care	  with	  the	  
outcome,	  readmission	  or	  mortality,	  attributed	  to	  the	  hospital	  where	  the	  patient	  was	  
admitted	  first.	  	  Patients	  who	  were	  discharged	  against	  medical	  advice	  and	  patients	  who	  
were	  discharged	  alive	  within	  the	  first	  day	  after	  admission	  were	  excluded	  from	  the	  
calculation	  of	  risk-­‐standardized	  readmission	  rates	  and	  risk-­‐standardized	  mortality	  rates.	  	  
Part	  II:	  Modified	  Regional	  Admission	  Rates	  
	   For	  the	  analysis	  in	  Part	  II,	  regional	  hospitalization	  rates	  for	  AMI	  and	  HF	  were	  
calculate	  as	  mentioned	  above	  with	  one	  modification.	  To	  prevent	  a	  circular	  analysis	  in	  
the	  analysis	  comparing	  hospitalization	  rates	  to	  readmission	  and	  mortality	  rates,	  any	  
hospitalization	  that	  occurred	  within	  30	  days	  of	  an	  indexed	  hospitalization	  were	  not	  
counted	  towards	  a	  regions	  hospitalization	  rate.	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Part	  II:	  Statistical	  Analysis	  
Risk-­‐standardized	  readmission	  and	  mortality	  rates	  for	  AMI	  and	  HF	  were	  
estimated	  using	  hierarchical	  logistic-­‐regression	  models	  for	  death	  or	  readmission	  within	  
30	  days	  of	  indexed	  hospitalization.	  Readmission	  and	  mortality	  rates	  were	  adjusted	  for	  
age,	  sex	  and	  clinical	  characteristics.	  The	  mortality	  measure	  for	  AMI	  included	  10	  
cardiovascular	  clinical	  characteristics	  and	  15	  coexisting	  conditions	  and	  the	  mortality	  
measure	  for	  HF	  included	  8	  cardiovascular	  characteristics	  and	  14	  coexisting	  conditions.	  	  
The	  readmission	  measure	  for	  AMI	  included	  10	  cardiovascular	  clinical	  characteristics	  and	  
19	  coexisting	  conditions	  and	  the	  readmission	  measure	  for	  HF	  included	  9	  cardiovascular	  
characteristics	  and	  26	  coexisting	  conditions	  (see	  supplemental	  table	  D-­‐G	  for	  details).	  	  
Hierarchical	  modeling	  was	  used	  to	  account	  for	  the	  clustering	  of	  outcomes	  within	  
hospitals.	  The	  models	  estimate	  readmission	  and	  mortality	  rates	  as	  a	  function	  of	  patient	  
level	  characteristics	  outlined	  above	  and	  as	  a	  function	  of	  a	  random	  hospital-­‐specific	  
effect.	  	  Hospital-­‐level	  random	  intercepts	  are	  assumed	  to	  be	  normally	  distributed	  to	  
account	  for	  clustering	  and	  permit	  separation	  of	  inter-­‐	  and	  intra-­‐hospital	  variation.	  	  	  The	  
rates	  are	  calculated	  as	  a	  ratio	  of	  predicted	  to	  expected	  readmissions	  or	  deaths.	  	  The	  
expected	  number	  of	  events	  is	  estimated	  using	  an	  individual	  hospital’s	  patient	  mix	  and	  
the	  average	  hospital	  specific	  intercept	  term	  whereas	  the	  predicted	  number	  of	  events	  is	  
estimated	  using	  an	  individual	  hospital’s	  patient	  mix	  and	  the	  individual	  hospital-­‐specific	  
intercept	  term.	  	  The	  risk-­‐standardized	  readmission	  and	  mortality	  rate	  are	  calculated	  by	  
multiplying	  the	  ratio	  of	  predicted	  to	  expected	  by	  the	  unadjusted	  national	  readmission	  or	  
mortality	  rate.	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The	  RSRR	  and	  RSMR	  models	  for	  AMI	  and	  HF	  were	  developed	  for	  CMS,	  have	  been	  
endorsed	  by	  the	  National	  Quality	  Forum	  and	  adhere	  to	  national	  published	  standards	  for	  
outcome	  measures.34	  Mortality	  and	  readmission	  models	  are	  based	  on	  administrative	  
data	  and	  validated	  against	  models	  using	  medical	  records.20,	  21,	  35	  
Hospital	  risk-­‐standardized	  mortality	  and	  readmission	  rates	  were	  linked	  to	  the	  
2006	  AHA	  Annual	  Survey	  of	  Hospitals	  using	  Medicare	  provider	  ID	  number	  for	  
geographical	  information.	  	  HRR	  level	  risk-­‐standardized	  readmission	  and	  mortality	  rates	  
were	  produced	  using	  a	  volume-­‐weighted	  aggregation.	  	  
The	  relationships	  between	  regional	  hospitalization	  rates	  and	  both	  risk	  
standardized	  readmission	  and	  mortality	  rates	  were	  characterized	  using	  a	  volume-­‐
weighted	  least	  squares	  regression.	  Ninety	  five	  percent	  confidence	  interval	  was	  
calculated	  for	  each	  regression	  coefficient	  (R2)	  by	  use	  of	  the	  Fisher	  transformation.	  	  
Analyses	  
Risk	  standardized	  readmission	  and	  mortality	  rates	  for	  AMI	  and	  HF	  were	  
developed	  at	  the	  Yale	  Center	  for	  Outcomes	  Research	  and	  Evaluation	  (CORE).	  	  For	  this	  
analysis,	  hospital	  level	  output	  of	  risk	  standardized	  readmission	  and	  mortality	  rates	  for	  
AMI	  and	  HF	  were	  produced	  by	  Changqin	  Wang,	  MD,	  SM,	  and	  Zhenqiu	  Lin,	  PhD.	  	  All	  
analyses	  were	  complete	  by	  Sachin	  Shah.	  Analyses	  were	  completed	  with	  the	  use	  of	  SAS	  
software,	  version	  9.1.3	  (SAS	  Institute),	  JMP	  software,	  version	  9.0.0	  (SAS	  Institute),	  and	  
Access	  2007	  software,	  (Microsoft).	  All	  statistical	  tests	  were	  two-­‐tailed	  and	  used	  a	  type	  I	  
error	  rate	  of	  0.05.	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Results	  
Admission	  Rates	  
We	  indentified	  826,855	  admissions	  for	  AMI	  (AMI)	  at	  3,927	  hospitals	  between	  
2006	  and	  2008.	  	  During	  the	  same	  time,	  we	  identified	  1,838,372	  admissions	  for	  HF	  at	  
4,404	  hospitals.	  	  Among	  the	  306	  hospital	  referral	  regions	  (HRRs),	  the	  AMI	  hospitalization	  
rate	  (admissions	  per	  1,000	  enrollees)	  ranged	  from	  2.3	  to	  23.9,	  with	  mean	  of	  10.0	  and	  a	  
standard	  deviation	  of	  2.7	  (Figure	  1).	  	  HF	  hospitalization	  rate	  (admissions	  per	  1,000	  
enrollees)	  ranged	  from	  8.0	  to	  45.5	  with	  a	  mean	  of	  21.7	  and	  a	  standard	  deviation	  of	  6.4.	  	  
State	  admission	  rates	  for	  AMI	  and	  HF	  displayed	  similar	  distribution	  patterns.	  	  
Among	  the	  50	  states,	  the	  AMI	  hospitalization	  rate	  (admissions	  per	  1,000	  enrollees)	  
ranged	  from	  5.4	  to	  13.8	  with	  a	  mean	  of	  9.6	  and	  a	  standard	  deviation	  of	  1.9	  (Figure	  2).	  HF	  
hospitalization	  rate	  (admissions	  per	  1,000	  enrollees)	  ranged	  from	  9.9	  to	  31.8,	  with	  a	  
mean	  of	  20.3	  and	  a	  standard	  deviation	  of	  5.7.	  
Variation	  
	   The	  volume-­‐weighted	  coefficient	  of	  variation	  (CVW)	  for	  regional	  AMI	  and	  HF	  
admission	  rates	  were	  0.24	  and	  0.26,	  respectively	  (Table	  1).	  	  Historic	  data	  from	  2005	  
shows	  the	  coefficient	  of	  variation	  for	  admission	  rates	  of	  common	  conditions	  varies	  from	  
0.09,	  for	  colon	  resection	  for	  colon	  cancer	  to	  0.39	  for	  gastroenteritis.	  The	  variation	  in	  
regional	  admission	  rates	  for	  colectomy	  and	  hip	  fracture	  were	  38%	  and	  48%	  of	  the	  
variation	  observed	  in	  AMI	  and	  HF	  admission	  rates,	  respectively.	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Part	  I:	  Admission	  Rates	  and	  Individual	  Cardiovascular	  Risk	  Factors	  
	   All	  individual	  cardiovascular	  risk	  factors	  were	  significantly	  associated	  with	  AMI	  
hospitalization	  rates	  (Figure	  3).	  Statewide	  prevalence	  of	  cardiovascular	  disease	  (angina	  
or	  coronary	  artery	  disease)	  had	  the	  strongest	  association	  with	  statewide	  AMI	  
hospitalization	  rates	  (R2	  of	  0.42,	  p<0.001),	  (Table	  2).	  	  Statewide	  prevalence	  of	  daily	  
tobacco	  use	  had	  the	  weakest	  association	  with	  statewide	  AMI	  hospitalization	  rates	  (R2	  of	  
0.14,	  p=0.008).	  Statewide	  prevalence	  of	  diabetes,	  high	  cholesterol,	  obesity,	  inactivity,	  
hypertension	  and	  prior	  history	  of	  AMI	  were	  all	  significantly	  associated	  with	  statewide	  
AMI	  hospitalization	  rates	  (p<0.05	  for	  all).	  
	   All	  individual	  cardiovascular	  risk	  factors	  were	  significantly	  associated	  with	  HF	  
hospitalization	  rates	  (Figure	  4).	  The	  statewide	  prevalence	  of	  inactive	  adults	  (adults	  not	  
meeting	  recommended	  amount	  of	  physical	  activity)	  had	  the	  strongest	  association	  with	  
statewide	  HF	  hospitalization	  rates	  (R2	  of	  0.54,	  p<0.001),	  (Table	  3).	  	  Statewide	  prevalence	  
of	  high	  cholesterol	  had	  the	  weakest	  association	  with	  statewide	  HF	  hospitalization	  rates	  
(R2	  of	  0.12,	  p=0.013).	  Statewide	  prevalence	  of	  diabetes,	  daily	  tobacco	  use,	  obesity,	  
hypertension,	  prior	  history	  of	  AMI	  and	  cardiovascular	  disease	  (angina	  or	  coronary	  artery	  
disease),	  were	  all	  significantly	  associated	  with	  statewide	  HF	  hospitalization	  rates	  (p<0.05	  
for	  all).	  	  
Part	  I:	  Cardiovascular	  Risk	  Profile	  as	  Predictive	  of	  State	  Hospitalization	  Rates	  
The	  summary	  of	  fit	  of	  the	  cardiovascular	  risk	  profile	  model	  used	  to	  predict	  
statewide	  AMI	  hospitalization	  rates	  is	  shown	  in	  Table	  4.	  The	  model	  produces	  an	  R2	  of	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0.49	  (observed	  vs.	  predicted),	  and	  the	  composite	  model	  has	  an	  F	  statistic	  of	  5.02	  
(p<0.001),	  (Figure	  5	  and	  Table	  4).	  	  
The	  summary	  of	  fit	  of	  the	  cardiovascular	  risk	  profile	  model	  used	  to	  predict	  
statewide	  HF	  hospitalization	  rates	  is	  shown	  in	  Table	  5.	  	  The	  model	  produced	  an	  R2	  of	  
0.51	  (observed	  vs.	  predicted),	  and	  the	  composite	  model	  has	  an	  F	  statistic	  of	  5.25	  
(p<0.001),	  (Figure	  6	  and	  Table	  5).	  	  	  
Part	  II:	  Admission	  Rates	  and	  Risk	  Standardized	  Readmission	  Rates	  (RSRRs)	  
The	  volume-­‐weighted	  linear	  regression	  shows	  regional	  AMI	  hospitalization	  rate	  
to	  be	  weakly	  associated	  with	  regional	  AMI	  risk-­‐standardized	  readmission	  rate	  (R2	  of	  
0.05,	  95%CI	  0.01-­‐0.11,	  p<0.001),	  (Figure	  7).	  In	  contrast,	  regional	  HF	  hospitalization	  rate	  
was	  modestly	  associated	  with	  HF	  risk-­‐standardized	  readmission	  rate	  (R2	  of	  0.32,	  95%CI	  
0.23-­‐0.40,	  p<0.001),	  (Figure	  8).	  	  
Cross-­‐condition	  analysis	  showed	  that	  regional	  AMI	  hospitalization	  rate	  was	  
weakly	  albeit	  significantly	  associated	  with	  HF	  risk-­‐standardized	  readmission	  rate	  (R2	  of	  
0.07,	  95%CI	  0.02-­‐0.13,	  p<0.001),	  (Figure	  9).	  In	  contrast,	  regional	  HF	  hospitalization	  rate	  
was	  modestly	  associated	  with	  AMI	  risk-­‐standardized	  readmission	  rate	  (R2	  of	  0.28,	  95%CI	  
0.20-­‐0.37,	  p<0.001),	  (Figure	  10).	  
Part	  II:	  Admission	  Rates	  and	  Risk	  Standardized	  Mortality	  Rates	  (RSMRs)	  
Volume-­‐weighted	  linear	  regression	  shows	  regional	  AMI	  hospitalization	  rate	  was	  
not	  significantly	  associated	  with	  regional	  AMI	  risk-­‐standardized	  mortality	  rate	  (R2	  of	  0.0,	  
95%CI	  0.00-­‐0.04,	  p=0.07),	  (Figure	  11).	  In	  contrast,	  regional	  HF	  hospitalization	  rate	  was	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modestly	  and	  inversely	  associated	  with	  HF	  risk-­‐standardized	  mortality	  rate	  (R2	  of	  0.17,	  
95%CI	  0.10-­‐0.25,	  p<0.001),	  (Figure	  12).	  	  
Cross-­‐condition	  analysis	  showed	  that	  regional	  AMI	  hospitalization	  rate	  was	  
weakly,	  albeit	  significantly,	  associated	  with	  HF	  RSMR	  (R2	  of	  0.03,	  95%CI	  0.00-­‐0.08,	  
p=0.004),	  (Figure	  13).	  Regional	  HF	  hospitalization	  rate	  was	  not	  significantly	  associated	  
with	  AMI	  risk-­‐standardized	  mortality	  rate	  (R2	  of	  0.00,	  95%CI	  0.00-­‐0.02,	  p=0.619),	  (Figure	  
14).	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Discussion	  	  
In	  line	  with	  previous	  work,	  we	  found	  that	  there	  continues	  to	  be	  considerable	  
regional	  variation	  in	  hospitalization	  rate	  for	  cardiovascular	  disease.	  The	  causes	  and	  
implications	  of	  this	  variation	  are	  important	  to	  patients,	  physicians	  and	  policymakers	  
alike.	  	  
In	  Part	  I	  of	  this	  analysis	  we	  found	  that	  statewide	  prevalence	  of	  traditional	  
cardiovascular	  risk	  factors	  are	  modestly	  associated	  with	  statewide	  AMI	  and	  HF	  
hospitalization	  rates.	  In	  aggregate,	  the	  cardiovascular	  risk	  profile	  explains	  49%	  of	  the	  
variation	  observed	  in	  statewide	  AMI	  hospitalization	  rates.	  	  Similarly,	  in	  aggregate,	  the	  
cardiovascular	  risk	  profile	  explains	  65%	  of	  the	  variation	  observed	  in	  statewide	  HF	  
hospitalization	  rates.	  While	  much	  of	  the	  variation	  in	  admission	  rates	  is	  explained	  by	  the	  
underlying	  burden	  of	  cardiovascular	  risk	  factors,	  a	  large	  portion	  of	  the	  variation	  is	  
unexplained	  and	  may	  be	  unwarranted.	  	  While	  this	  is	  consistent	  with	  prior	  examinations	  
of	  all-­‐cause	  admission	  rates	  and	  general	  population	  health,	  this	  relationship	  has	  not	  
been	  previously	  quantified	  for	  cardiovascular	  hospitalization.	  	  
Given	  the	  less	  discretionary	  nature	  of	  AMI	  admissions	  relative	  to	  HF	  admissions,	  
we	  expected	  regional	  cardiovascular	  risk	  profile	  would	  explain	  larger	  portion	  of	  the	  
variation	  in	  AMI	  hospitalization	  rates	  relative	  to	  HF	  hospitalization	  rates.	  We	  did	  not	  
observe	  this,	  which	  may	  be	  due	  to	  ecologic	  fallacy,	  a	  limitation	  in	  our	  study	  design	  
described	  below.	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In	  Part	  II	  of	  this	  analysis,	  we	  found	  that	  regional	  variation	  in	  AMI	  risk-­‐
standardized	  readmission	  rates	  and	  risk-­‐standardized	  mortality	  rates	  are	  not	  explained	  
by	  regional	  variation	  in	  AMI	  hospitalization	  rates.	  This	  is	  consistent	  with	  prior	  
observations	  that	  admission	  for	  AMI	  is	  less	  discretionary	  than	  other	  conditions.	  	  
On	  the	  other	  hand,	  we	  found	  that	  HF	  risk-­‐standardized	  readmission	  rates	  are	  
explained	  in	  part	  by	  HF	  hospitalization	  rates.	  This	  observation	  is	  lent	  additional	  weight	  
because,	  in	  the	  cross-­‐condition	  analysis,	  we	  found	  that	  AMI	  risk-­‐standardized	  
readmission	  rates	  are	  also	  explained	  in	  part	  by	  HF	  hospitalization	  rates.	  We	  believe	  the	  
two	  observations	  taken	  together	  provide	  evidence	  for	  a	  causal	  relationship	  -­‐-­‐	  expressly	  
that	  regional	  HF	  hospitalization	  rate	  carries	  some	  information	  about	  the	  regional	  
propensity	  to	  admit.	  	  
In	  addition,	  we	  came	  upon	  an	  observation	  that	  suggests	  regional	  variation	  in	  HF	  
risk-­‐standardized	  mortality	  rates	  are	  explained	  in	  part	  by	  regional	  HF	  hospitalization	  
rates	  -­‐-­‐	  specifically	  that	  regions	  with	  high	  HF	  hospitalization	  rates	  tend	  to	  have	  lower	  HR	  
risk-­‐standardized	  mortality	  rates.	  The	  casual	  nature	  of	  this	  relationship	  was	  called	  into	  
question	  when	  the	  cross-­‐condition	  analysis	  showed	  none	  of	  the	  variation	  in	  AMI	  risk-­‐
standardized	  mortality	  rates	  was	  explain	  HF	  admission	  rates.	  	  We	  believe	  the	  two	  
observations	  taken	  together	  provide	  evidence	  that	  the	  observed	  relationship	  between	  
regional	  HF	  risk-­‐standardized	  mortality	  rate	  and	  HF	  hospitalization	  rate	  is	  due	  to	  an	  
unmeasured	  confounder.	  	  Specifically,	  we	  believe	  that	  regions	  with	  higher	  HF	  
hospitalization	  rates	  may	  be	  admitting	  healthier	  patients	  whose	  minimal	  risk	  of	  death	  is	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not	  inadequately	  captured	  by	  the	  risk	  standardization	  model	  and	  therefore	  it	  appears	  as	  
though	  regions	  with	  higher	  hospitalization	  rates	  provide.	  	  
Forty	  years	  after	  variation	  in	  inpatient	  utilization	  was	  first	  described,	  we	  believe	  
our	  study	  add	  to	  the	  understanding	  of	  this	  variation	  in	  two	  key	  ways.	  	  
First,	  as	  studies	  examine	  the	  implications	  of	  the	  regional	  variation	  in	  inpatient	  
utilization,	  we	  believe	  this	  work	  demonstrates	  that	  large	  variation	  in	  hospitalization	  
rates	  are	  unexplained	  by	  regional	  variation	  in	  risk	  profiles.	  	  	  	  
Second,	  we	  found	  that	  variation	  in	  HF	  and	  AMI	  risk-­‐standardized	  readmission	  
rates	  are	  explained	  in	  part	  by	  regional	  HF	  hospitalization	  rates	  but	  are	  not	  explained	  by	  
regional	  AMI	  hospitalization	  rates.	  	  We	  believe	  this	  association	  is	  due	  to	  the	  observation	  
that	  HF	  admissions	  are	  more	  discretionary	  than	  AMI	  admissions;	  in	  fact,	  we	  believe	  that	  
regional	  HF	  hospitalization	  rate	  is	  a	  marker	  for	  regional	  propensity	  to	  admit	  (and	  
readmit)	  patients.	  In	  this	  study	  we	  were	  not	  able	  to	  examine	  the	  association	  between	  
cardiovascular	  risk	  profile	  adjusted	  regional	  admission	  rate	  and	  regional	  outcomes.	  	  This	  
is	  our	  next	  step	  and	  we	  believe	  that	  analysis	  will	  allow	  for	  a	  more	  precise	  examination	  of	  
the	  unmeasured	  regional	  propensity	  to	  admit.	  	  	  
Our	  study	  had	  a	  number	  of	  limitations.	  	  First,	  our	  statewide	  analysis	  is	  subject	  to	  
ecologic	  fallacy	  -­‐-­‐	  the	  misattribution	  of	  regional	  characteristics	  to	  individuals.	  However,	  
we	  are	  unable	  to	  remedy	  this	  given	  the	  paucity	  of	  patient	  level	  risk	  factor	  data.	  Second,	  
we	  only	  examined	  AMI	  and	  HF	  and	  the	  findings	  may	  not	  be	  easily	  translated	  other	  
common	  medical	  conditions	  such	  as	  pneumonia.	  Third,	  regional	  RSMRs	  and	  RSRRs	  were	  
calculated	  using	  volume-­‐weighted	  aggregation	  where	  a	  more	  precise	  regional	  estimate	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could	  be	  developed	  using	  a	  three	  level	  hierarchical	  model.	  Finally,	  we	  examined	  AMI	  
and	  HF	  outcomes	  with	  respect	  to	  mortality	  and	  readmission	  and	  did	  not	  examine	  
functional	  health	  status,	  which	  was	  not	  possible	  with	  administrative	  data.	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  Cardiovascular	  quality	  and	  outcomes	  2008;1:29-­‐
37.	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Figures	  References	  and	  Legends	  	  
Figure	  1. Distribution	  and	  Central	  Tendencies	  of	  Regional	  Acute	  Myocardial	  Infarction	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Figure	  2. Distribution	  and	  Central	  Tendencies	  of	  State	  Acute	  Myocardial	  Infarction	  Admissions	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Figure	  3. Bivariate	  Comparisons	  between	  Statewide	  Prevalence	  of	  Individual	  Cardiovascular	  




Panel	  B:	  High	  Cholesterol
	  
Panel	  C:	  Daily	  Smokers
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Figure	  4. Bivariate	  Comparisons	  between	  Statewide	  Prevalence	  of	  Individual	  Cardiovascular	  






Panel	  C:	  Daily	  Smokers
	  












	  	   36	  
Figure	  5. Volume-­‐Weighted	  Multivariate	  Model	  of	  Cardiovascular	  Risk	  Profile	  as	  Predictive	  of	  
Statewide	  Acute	  Myocardial	  Infarction	  Admission	  Rates	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Figure	  6. Volume-­‐Weighted	  Multivariate	  Model	  of	  Cardiovascular	  Risk	  Profile	  as	  Predictive	  of	  
Statewide	  Heart	  Failure	  Admission	  Rates	  from	  2006	  to	  2008	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Figure	  7. Relationship	  between	  Regional	  Acute	  Myocardial	  Infarction	  Admission	  Rate	  and	  Risk-­‐
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Figure	  9. Relationship	  between	  Regional	  Acute	  Myocardial	  Infarction	  Admission	  Rate	  and	  
Regional	  Heart	  Failure	  Risk-­‐Standardized	  Readmission	  Rate	  
	  
	  
Figure	  10. Relationship	  between	  Regional	  Heart	  Failure	  Admission	  Rate	  and	  Regional	  Acute	  
Myocardial	  Infarction	  Risk-­‐Standardized	  Readmission	  Rate	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Figure	  11. Relationship	  between	  Regional	  Acute	  Myocardial	  Infarction	  Admission	  Rate	  and	  Risk-­‐
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Figure	  13. Relationship	  between	  Regional	  Acute	  Myocardial	  Infarction	  Admission	  Rate	  and	  
Regional	  Heart	  Failure	  Risk-­‐Standardized	  Mortality	  Rate	  
	  
	  
Figure	  14. Relationship	  between	  Regional	  Heart	  Failure	  Admission	  Rate	  and	  Regional	  Acute	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Tables	  




(Admission	  per	  1,000	  
Medicare	  Enrollees)	   Mean	  
Standard	  








-­‐	  Conditions	  in	  Current	  Analysis	  (2006-­‐2008)	  -­‐	  
Acute	  Myocardial	  Infarction	   10.0	   2.7	   2.3-­‐23.9	   0.24	   1.00	  
Heart	  Failure	   21.7	   6.4	   8.0-­‐45.5	   0.26	   1.08	  
-­‐	  Historic	  Data	  for	  Comparison	  (2005)	  -­‐	  
Percutaneous	  Coronary	  
Intervention	  (PCI)	   11.39	   2.29	   7.42-­‐16.71	   0.20	   0.83	  
Angiography	   21.89	   4.31	   14.64-­‐33.31	   0.20	   0.83	  
Coronary	  Artery	  Bypass	  
Surgery	  (CABG)	   4.86	   0.91	   2.81-­‐6.61	   0.19	   0.79	  
Hip	  Fracture	   7.53	   0.77	   6.37-­‐9.09	   0.10	   0.48	  
Resection	  for	  Colon	  Cancer	   1.71	   0.16	   1.30-­‐2.01	   0.09	   0.38	  
Angina	   1.04	   0.31	   0.59-­‐1.91	   0.30	   1.25	  
Gasteroenteritis	   1.35	   0.52	   0.51-­‐2.93	   0.39	   1.63	  
	  
Table	  2:	  Bivariate	  Comparison	  between	  Statewide	  Prevalence	  of	  Individual	  
Cardiovascular	  Risk	  Factors	  and	  Acute	  Myocardial	  Infarction	  Admission	  Rates	  
Risk	  Factor	   Slope	  
Standard	  
Error	   R2	   P	  Value	  
Prevalence	  of	  Diabetes	   0.49	   0.17	   0.15	   0.006	  
Prevalence	  of	  High	  Cholesterol	   0.36	   0.12	   0.17	   0.003	  
Percent	  Daily	  Smokers	   0.24	   0.09	   0.14	   0.008	  
Percent	  Current	  Smokers	   0.21	   0.08	   0.12	   0.016	  
Prevalence	  of	  Obesity	   0.20	   0.09	   0.09	   0.037	  
Percent	  Adults	  Inactivity	   0.16	   0.05	   0.17	   0.003	  
Prevalence	  of	  Hypertension	   0.30	   0.08	   0.21	   <0.001	  
Prevalence	  of	  Prior	  History	  of	  AMI	   1.35	   0.28	   0.32	   <0.001	  
Prevalence	  of	  Angina/CAD	   1.33	   0.23	   0.42	   <0.001	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Table	  3:	  Bivariate	  Comparison	  between	  Statewide	  Prevalence	  of	  Individual	  
Cardiovascular	  Risk	  Factors	  and	  Heart	  Failure	  Admission	  Rates	  
Risk	  Factor	   Slope	  
Standard	  
Error	   R2	   P	  Value	  
Prevalence	  of	  Diabetes	   2.53	   0.41	   0.44	   <0.001	  
Prevalence	  of	  High	  Cholesterol	   0.91	   0.35	   0.12	   0.013	  
Percent	  Daily	  Smokers	   0.71	   0.26	   0.13	   0.009	  
Percent	  Current	  Smokers	   0.72	   0.24	   0.16	   0.004	  
Prevalence	  of	  Obesity	   1.01	   0.25	   0.26	   <0.001	  
Percent	  Adults	  Inactivity	   0.86	   0.11	   0.54	   <0.001	  
Prevalence	  of	  Hypertension	   1.31	   0.20	   0.46	   <0.001	  
Prevalence	  of	  Prior	  History	  of	  AMI	   3.64	   0.88	   0.26	   <0.001	  
Prevalence	  of	  Angina/CAD	   3.70	   0.71	   0.36	   <0.001	  
	  
Table	  4:	  Volume-­‐Weighted	  Multivariate	  Model	  of	  Cardiovascular	  Risk	  Profile	  as	  
Predictive	  of	  Statewide	  Acute	  Myocardial	  Infarction	  Admission	  Rates,	  Summary	  of	  Fit	  
(a),	  Analysis	  of	  Variance	  (b),	  and	  Parameter	  Estimates	  (c)	  
	  
Summary	  of	  Fit	   	  	  
RSquare	   0.49461	  
RSquare	  Adj	   0.395997	  
Root	  Mean	  Square	  Error	   156.4914	  
Mean	  of	  Response	   10.27332	  
Observations	  (or	  Sum	  Wgts)	   829684	  
	  
Analysis	  of	  Variance	  
Source	   DF	   Sum	  of	  Squares	   Mean	  Square	   F	  Ratio	  
Model	   8	   982654.9	   122832	   5.0157	  
Error	   41	   1004072.5	   24490	   Prob	  >	  F	  
C.	  Total	   49	   1986727.4	   	   0.0002*	  
	  
Parameter	  Estimates	  
Term	   Estimate	   Std	  Error	   t	  Ratio	   t	  Ratio	   Prob>|t|	  
Prevalence	  of	  Angina/CAD	   1.61775	   0.49976	   3.24	   	   0.0024*	  
Prevalence	  of	  Obese	  (BMI>30)	   -­‐0.1129	   0.12399	   -­‐0.91	   	   0.3679	  
Diabetes	  Prevalence	   -­‐0.2831	   0.31382	   -­‐0.90	   	   0.3722	  
Prevalence	  of	  HTN	   0.14516	   0.16422	   0.88	   	   0.3819	  
Prevalence	  of	  High	  Cholesterol	   -­‐0.0555	   0.14052	   -­‐0.40	   	   0.6948	  
Percent	  Daily	  Smokers	   0.01326	   0.13281	   0.10	   	   0.9209	  
Prevalence	  of	  Prior	  History	  of	  AMI	   -­‐0.0517	   0.57017	   -­‐0.09	   	   0.9282	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Table	  5:	  Volume-­‐Weighted	  Multivariate	  Model	  of	  Cardiovascular	  Risk	  Profile	  as	  
Predictive	  of	  Statewide	  Heart	  Failure	  Admission	  Rates,	  Summary	  of	  Fit	  (a),	  Analysis	  of	  
Variance	  (b),	  and	  Parameter	  Estimates	  (c)	  
	  
Summary	  of	  Fit	   	  	  
RSquare	   0.505898	  
RSquare	  Adj	   0.409487	  
Root	  Mean	  Square	  Error	   610.8854	  
Mean	  of	  Response	   23.1894	  
Observations	  (or	  Sum	  Wgts)	   1846603	  
	  
Analysis	  of	  Variance	  
Source	   DF	   Sum	  of	  Squares	   Mean	  Square	   F	  Ratio	  
Model	   8	   15665673	   1958209	   5.2473	  
Error	   41	   15300422	   373181	   Prob	  >	  F	  
C.	  Total	   49	   30966095	   	   0.0001*	  
	  
Parameter	  Estimates	  
Term	   Estimate	   Std	  Error	   t	  Ratio	   t	  Ratio	   Prob>|t|	  
Prevalence	  of	  Angina/CAD	   3.89068	   1.29854	   3.00	   	   0.0046*	  
Prevalence	  of	  HTN	   0.55920	   0.43763	   1.28	   	   0.2085	  
Prevalence	  of	  Prior	  History	  of	  AMI	   -­‐1.5199	   1.53551	   -­‐0.99	   	   0.3281	  
Percent	  Daily	  Smokers	   -­‐0.2379	   0.35594	   -­‐0.67	   	   0.5076	  
Percent	  Adults	  Inactive	   0.16414	   0.24913	   0.66	   	   0.5137	  
Prevalence	  of	  High	  Cholesterol	   -­‐0.2315	   0.36876	   -­‐0.63	   	   0.5336	  
Diabetes	  Prevalence	   0.24692	   0.81746	   0.30	   	   0.7641	  
Prevalence	  of	  Obese	  (BMI>30)	   -­‐0.02914	   0.33050	   -­‐0.09	   	   0.9302	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Table	  6:	  Relationship	  between	  Regional	  Admission	  Rates	  for	  Acute	  Myocardial	  Infarction	  





(Dependent)	   Slope	  
Standard	  
Error	   R2	  (95%	  CI)	   P	  Value	  
AMI	   AMI	   1.0	  X	  10-­‐3	   2.5	  X	  10-­‐4	   0.05	  (0.01-­‐0.11)	   <0.001*	  
HF	   HF	   1.4	  x	  10-­‐3	   1.2	  x	  10-­‐4	   0.32	  (0.23-­‐0.40)	   <0.001*	  
AMI	   HF	   1.5	  x	  10-­‐3	   3.3	  x	  10-­‐4	   0.07	  (0.02-­‐(0.13)	   <0.001*	  
HF	   AMI	   9.9	  x	  10-­‐4	   9.1	  X	  10-­‐5	   0.28(0.20-­‐0.37)	   <0.001*	  
	  
Table	  7:	  Relationship	  between	  Regional	  Admission	  Rates	  for	  Acute	  Myocardial	  Infarction	  





(Dependent)	   Slope	  
Standard	  
Error	   R2	  (95%	  CI)	   P	  Value	  
AMI	   AMI	   -­‐	  4.4	  x	  10-­‐4	   2.4	  x	  10-­‐4	   0.01	  (0.00-­‐0.04)	   0.067	  
HF	   HF	   -­‐	  7.5	  x	  10-­‐4	   9.4	  x	  10-­‐5	   0.17	  (0.10-­‐.25)	   <0.001*	  
AMI	   HF	   -­‐	  7.2	  x	  10-­‐4	   2.5	  x	  10-­‐4	   0.03	  (0.00-­‐0.08)	   0.004*	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Supplemental	  Tables	  
	  
Supplemental	  Table	  A:	  ICD-­‐9-­‐CM	  definition	  of	  Acute	  Myocardial	  Infarction	  
ICD-­‐9-­‐CM	   Description	  
410.00	   AMI	  (anterolateral	  wall)	  –	  episode	  of	  care	  unspecified	  
410.01	   AMI	  (anterolateral	  wall)	  –	  initial	  episode	  of	  care	  
410.10	   AMI	  (other	  anterior	  wall)	  –	  episode	  of	  care	  unspecified	  
410.11	   AMI	  (other	  anterior	  wall)	  –	  initial	  episode	  of	  care	  
410.20	   AMI	  (inferolateral	  wall)	  –	  episode	  of	  care	  unspecified	  
410.21	   AMI	  (inferolateral	  wall)	  –	  initial	  episode	  of	  care	  
410.30	   AMI	  (inferoposterior	  wall)	  –	  episode	  of	  care	  unspecified	  
410.31	   AMI	  (inferoposterior	  wall)	  –	  initial	  episode	  of	  care	  
410.40	   AMI	  (other	  inferior	  wall)	  –	  episode	  of	  care	  unspecified	  
410.41	   AMI	  (other	  inferior	  wall)	  –	  initial	  episode	  of	  care	  
410.50	   AMI	  (other	  lateral	  wall)	  –	  episode	  of	  care	  unspecified	  
410.51	   AMI	  (other	  lateral	  wall)	  –	  initial	  episode	  of	  care	  
410.60	   AMI	  (true	  posterior	  wall)	  –	  episode	  of	  care	  unspecified	  
410.61	   AMI	  (true	  posterior	  wall)	  –	  initial	  episode	  of	  care	  
410.70	   AMI	  (subendocardial)	  –	  episode	  of	  care	  unspecified	  
410.71	   AMI	  (subendocardial)	  –	  initial	  episode	  of	  care	  
410.80	   AMI	  (other	  specified	  site)	  –	  episode	  of	  care	  unspecified	  
410.81	   AMI	  (other	  specified	  site)	  –	  initial	  episode	  of	  care	  
410.90	   AMI	  (unspecified	  site)	  –	  episode	  of	  care	  unspecified	  
410.91	   AMI	  (unspecified	  site)	  –	  initial	  episode	  of	  care	  
	  
Supplemental	  Table	  B:	  ICD-­‐9-­‐CM	  definition	  of	  Heart	  Failure	  
ICD-­‐9-­‐CM	   Description	  
402.01	   Malignant	  hypertensive	  heart	  disease	  with	  congestive	  heart	  failure	  (CHF)	  
402.11	   Benign	  hypertensive	  heart	  disease	  with	  CHF	  
402.91	   Hypertensive	  heart	  disease	  with	  CHF	  
404.01	   Malignant	  hypertensive	  heart	  and	  renal	  disease	  with	  CHF	  
404.03	   Malignant	  hypertensive	  heart	  and	  renal	  disease	  with	  CHF	  &	  renal	  failure	  
(RF)	  
404.11	   Benign	  hypertensive	  heart	  and	  renal	  disease	  with	  CHF	  
404.13	   Benign	  hypertensive	  heart	  and	  renal	  disease	  with	  CHF	  &	  RF	  
404.91	   Unspecified	  hypertensive	  heart	  and	  renal	  disease	  with	  CHF	  
404.93	   Hypertension	  and	  non-­‐specified	  heart	  and	  renal	  disease	  with	  CHF	  &	  RF	  
428.xx	   Heart	  failure	  codes	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Supplemental	  Table	  C:	  2007	  BRFSS	  Cardiovascular	  Risk	  Factor	  Variables	  Defined	  
Source:	  BRFSS	  2007	  State	  Sample	  
Sample:	  State	  adult	  population	  (18+)	  	  
Variable	   Definition	  
Diabetes	   Percent	  of	  adults	  who	  answered	  yes	  to,	  “Have	  you	  ever	  been	  
told	  by	  a	  doctor	  that	  you	  have	  diabetes”	  excluding	  pregnancy	  
related	  diabetes	  
High	  Cholesterol	   Percent	  of	  adults	  who	  have	  had	  their	  cholesterol	  checked	  and	  
been	  told	  that	  it	  was	  high	  
Daily	  Smokers	   Percent	  of	  adults	  who	  currently	  smoke	  and	  smoke	  every	  day	  
Obese	   Percent	  of	  adults	  with	  BMI	  greater	  than	  30	  
Inactive	  Adults	   Percent	  of	  adults	  reporting	  neither	  30+	  min	  of	  moderate	  
physician	  activity	  5	  day	  or	  more/week	  nor	  vigorous	  physical	  
activity	  3	  or	  more	  days/week	  
HTN	   Percent	  of	  adults	  who	  have	  been	  told	  they	  have	  high	  blood	  
pressure	  
Prior	  MI	   Percent	  of	  adults	  reporting	  that	  they	  have	  ever	  had	  a	  heart	  
attack	  or	  myocardial	  infarction	  
Angina/CAD	   Percent	  of	  adults	  who	  have	  ever	  been	  told	  that	  they	  have	  angina	  
or	  coronary	  heart	  disease	  	  
	  
	  	   48	  
Supplemental	  Table	  D:	  Acute	  Myocardial	  Infarction	  Risk	  Standardized	  Readmission	  Rate	  
Model	  Variables	  
	  
Domain	   Variable	   Code(s)	  
Demographic	   Age-­‐65	  (years	  above	  65,	  continuous)	  	  
Male	  
n/a	  
Cardiovascular	   - History	  of	  PCI	  
	  
- History	  of	  CABG	  	  
- Congestive	  heart	  failure	  	  
- Acute	  coronary	  syndrome	  	  
- Anterior	  myocardial	  infarction	  	  
- Other	  location	  of	  myocardial	  infarction	  	  
- Angina	  pectoris/old	  myocardial	  infarction	  	  
- Coronary	  atherosclerosis/other	  chronic	  
ischemic	  heart	  disease	  	  
- Valvular	  and	  rheumatic	  heart	  disease	  
Arrhythmias	  
- ICD-­‐9-­‐CM	  V45.82,	  00.66,	  36.01,	  
36.02,	  36.05,	  36.06,	  36.07	  	  
- ICD-­‐9-­‐CM	  V45.81,	  36.10-­‐36.16	  
- CC	  80	  
- CC	  81,	  82	  	  
- ICD-­‐9-­‐CM	  410.00-­‐410.19	  	  
- ICD-­‐9-­‐CM	  410.20-­‐410.69	  	  
- CC	  83	  	  
- CC	  84	  
	  
- CC	  86	  	  
- CC	  92,	  93	  
Comorbidities	   - Cerebrovascular	  disease	  
- Stroke	  	  
- Vascular	  or	  circulatory	  disease	  
- Hemiplegia,	  paraplegia,	  paralysis,	  functional	  
disability	  
- Diabetes	  and	  DM	  complications	  
- Renal	  failure	  	  
- End-­‐stage	  renal	  disease	  or	  dialysis	  	  
- Other	  urinary	  tract	  disorders	  	  
- COPD	  
- History	  of	  pneumonia	  	  
- Asthma	  	  
- Disorders	  of	  fluid/electrolyte/acid-­‐base	  	  
- History	  of	  infection	  	  
- Metastatic	  cancer	  and	  acute	  leukemia	  	  
- Cancer	  	  
- Iron	  deficiency	  and	  other/unspecified	  
anemias	  and	  blood	  disease	  
- Decubitus	  ulcer	  or	  chronic	  skin	  ulcer	  	  
- Dementia	  and	  senility	  	  
- Protein-­‐calorie	  malnutrition	  
- CC	  97-­‐99,	  103	  	  
- CC	  95,	  96	  	  
- CC	  104-­‐106	  	  
- CC	  67-­‐69,	  100-­‐102,	  177,	  178	  
	  
- CC	  15-­‐20,	  119,	  120	  	  
- CC	  131	  	  
- CC	  129,	  130	  	  
- CC	  136	  
- CC	  108	  	  
- CC	  111-­‐113	  	  
- CC	  110	  	  
- CC	  22,	  23	  	  
- CC	  1,	  3-­‐6	  	  
- CC	  7	  	  
- CC	  8-­‐12	  	  
- CC	  47	  
	  
- CC	  148,	  149	  
- CC	  49,	  50	  	  
- CC	  21	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Supplemental	  Table	  E:	  Heart	  Failure	  Risk	  Standardized	  Readmission	  Rate	  Model	  
Variables	  
	  
Domain	   Variable	   Code(s)	  
Demographic	   Age-­‐65	  (years	  above	  65,	  continuous)	  	  
Male	  
n/a	  
Cardiovascular	   - History	  of	  CABG	  	  
- Congestive	  heart	  failure	  	  
- Acute	  coronary	  syndrome	  	  
- Arrhythmias	  Cardio-­‐respiratory	  failure	  and	  
shock	  	  
- Valvular	  and	  rheumatic	  heart	  disease	  	  
- Vascular	  or	  circulatory	  disease	  	  
- Chronic	  atherosclerosis	  	  
- Other	  and	  unspecified	  heart	  disease	  
	  
- CC	  80	  	  
- CC	  81,	  82	  	  
- CC	  92,	  93	  	  
- CC	  79	  	  
	  
- CC	  86	  	  
- CC	  104-­‐106	  	  
- CC	  83,	  84	  	  
- CC	  94	  
Comorbidities	   - Hemiplegia,	  paraplegia,	  paralysis,	  functional	  
disability	  	  
- Stroke	  	  
- Renal	  failure	  	  
- COPD	  
- Diabetes	  and	  DM	  complications	  	  
- Disorders	  of	  fluid/electrolyte/acid-­‐base	  	  
- Other	  urinary	  tract	  disorders	  	  
- Decubitus	  ulcer	  or	  chronic	  skin	  ulcer	  
- Other	  gastrointestinal	  disorders	  	  
- Peptic	  ulcer,	  hemorrhage,	  other	  specified	  
gastrointestinal	  disorders	  	  
- Severe	  hematological	  disorders	  	  
- Nephritis	  	  
- Dementia	  and	  senility	  	  
- Metastatic	  cancer	  and	  acute	  leukemia	  	  
- Cancer	  Liver	  and	  biliary	  disease	  	  
- End-­‐stage	  renal	  disease	  or	  dialysis	  	  
- Asthma	  Iron	  deficiency	  and	  
other/unspecified	  anemias	  and	  blood	  disease	  	  
- Pneumonia	  	  
- Drug/alcohol	  abuse/dependence/psychosis	  	  
- Major	  pysch	  disorders	  	  
- Depression	  	  
- Other	  psychiatric	  disorders	  	  
- Fibrosis	  of	  lung	  and	  other	  chronic	  lung	  
disorders	  	  
- Protein-­‐calorie	  malnutrition	  
- CC	  67-­‐69,	  100-­‐102,	  177,	  178	  	  
	  
- CC	  95,	  96	  	  
- CC	  131	  	  
- CC	  108	  
- CC	  15-­‐20,	  119,	  120	  	  
- CC	  22,	  23	  	  
- CC	  136	  	  
- CC	  148,	  149	  
- CC	  36	  	  
- CC	  34	  	  
- CC	  44	  	  
	  
- CC	  132	  	  
- CC	  49,	  50	  	  
- CC	  7	  
- CC	  8-­‐12	  	  
- CC	  25-­‐30	  	  
- CC	  129,	  130	  	  
- CC	  110	  CC	  47	  	  
	  
- CC	  111-­‐113	  	  
- CC	  51-­‐53	  	  
- CC	  54-­‐56	  	  
- CC	  58	  	  
- CC	  60	  	  
- CC	  109	  	  
	  
- CC	  21	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Supplemental	  Table	  F:	  Acute	  Myocardial	  Infarction	  Risk	  Standardized	  Mortality	  Rate	  
Model	  Variables	  
	  
Domain	   Variable	   Code(s)	  
Demographic	   Age-­‐65	  (years	  above	  65,	  continuous)	  	  
Male	  
n/a	  
Cardiovascular	   - History	  of	  PTCA	  	  
- History	  of	  CABG	  	  
- History	  of	  heart	  failure	  (HCC	  80)	  	  
- History	  of	  MI	  (HCC	  81)	  	  
- AntMI_1	  (ICD9	  410.00-­‐410.19)	  	  
- AntMI_2	  (ICD9	  410.20-­‐410.69)	  	  
- Unstable	  angina	  (HCC	  82)	  	  
- Chronic	  atherosclerosis	  (HCC	  83,	  84)	  	  
- Cardiopulmonary-­‐respiratory	  failure	  
- and	  shock	  (HCC	  79)	  
- Valvular	  heart	  disease	  (HCC	  86)	  
	  
	  
- HCC	  80	  
- HCC	  81	  
- ICD9	  410.00-­‐410.19	  
- ICD9	  410.20-­‐410.69	  
- HCC	  82	  
- HCC	  83,	  84	  
- HCC	  79	  
	  
- HCC	  86	  
Comorbidities	   - Hypertension	  
- Stroke	  	  
- Cerebrovascular	  disease	  	  
- Renal	  failure	  	  
- COPD	  	  
- Pneumonia	  	  
- Diabetes	  	  
- Protein-­‐calorie	  malnutrition	  	  
- Dementia	  	  
- Hemiplegia,	  paraplegia,	  paralysis,	  
functional	  disability	  	  
- Peripheral	  vascular	  disease	  	  
- Metastatic	  cancer	  	  	  
- Trauma	  in	  last	  year	  	  
- Major	  psych	  disorders	  	  
- Chronic	  liver	  disease	  	  
- HCC	  89,	  91	  
- HCC	  95,	  96	  
- HCC	  97-­‐99,	  103	  
- HCC	  131	  
- HCC	  108	  
- HCC	  111-­‐113	  
- HCC	  15-­‐20,	  120	  
- HCC	  21	  
- HCC	  49,	  50	  
- HCC	  100-­‐102,	  68,	  69,	  177,	  178	  
	  
- HCC	  104,	  105	  
- HCC	  7,	  8	  
- HCC	  154-­‐156,	  158-­‐162	  
- HCC	  54-­‐56	  
- HCC	  25-­‐27	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Supplemental	  Table	  G:	  Heart	  Failure	  Risk	  Standardized	  Mortality	  Rate	  Model	  Variables	  
	  
Domain	   Variable	   Code(s)	  
Demographic	   Age-­‐65	  (years	  above	  65,	  continuous)	  	  
Male	  
n/a	  
Cardiovascular	   - History	  of	  PCTA	  
- History	  of	  CABG	  
- History	  of	  heart	  failure	  
- History	  of	  AMI	  
- Unstable	  angina	  
- Chronic	  atherosclerosis	  
- Cardiopulmonary-­‐respiratory	  failure	  and	  
shock	  




- HCC	  80	  
- HCC	  81	  
- HCC	  82	  
- HCC	  83,	  84	  
- HCC	  79	  
	  
- HCC	  86	  
Comorbidities	   - Hypertension	  
- Stroke	  




- Protein-­‐calorie	  malnutrition	  
- Dementia	  
- Hemiplegia,	  paraplegia,	  paralysis,	  functional	  
disability	  
- Peripheral	  vascular	  disease	  
- Metastatic	  cancer	  
- Trauma	  in	  last	  year	  
- Major	  psychiatric	  disorder	  
- Chronic	  liver	  disease	  
- HCC	  89,	  91	  
- HCC	  95,	  96	  
- HCC	  131	  
- HCC	  108	  
- HCC	  111-­‐113	  
- HCC	  15-­‐20,	  120	  
- HCC	  21	  
- HCC	  49,	  50	  
- HCC	  100-­‐102,	  68,	  69,	  177,	  178	  
	  
- HCC	  104,	  105	  
- HCC	  7,	  8	  
- HCC	  154-­‐156,	  158-­‐162	  
- HCC	  54-­‐56	  
- HCC	  25-­‐27	  
	  
	  
	  
